Dr. Colette Ngozi Owens, MD

Dr. Owens practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Owens' NPI, 1518284611, was assigned on April 28, 2010. Dr. Owens graduated from Rutgers Robert Wood Johnson Medical School in 2010. Dr. Owens' New York license number on file is 266080.

Dr. Owens' primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Owens' primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Hematology Lymphoma Group. Dmand AI also links Dr. Owens to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Owens practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Owens' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Owens is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Owens' licenses on file in 3 states: New York, Florida and New Jersey.

Dmand AI lists breast cancer, chronic leukemia, immune deficiency disease, lung cancer, lymphoma, multiple myeloma, prostate cancer and purpura and thrombocytopenia among the conditions Dr. Owens treats.

CMS data shows 1,126 Medicare services from Dr. Owens across 5 procedure codes in 2024, for 478 Medicare patients. Medicare paid $95,588 for them.

CMS counts 478 Medicare patients who saw Dr. Owens in 2024. The largest group is 65 to 74, with 198 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Owens' median patient age at 75, with 49% women.

In 2024, Dr. Owens wrote 588 Medicare Part D claims for 144 patients. 79% of them were for generic drugs. CMS names the drug for 408 of them, across 11 drugs with 11 or more claims each, at $1,224,242 in total drug cost. In 2023, CMS named 315 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Owens for performance year 2024, reported as part of a group. Dr. Owens accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Owens as offering telehealth.

Dmand AI links 15 papers to Dr. Owens, published from 2019 to 2025. 2022 was the busiest year, with 4. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Doxorubicin and Lymphoma, Large B-Cell, Diffuse. Dr. Owens has published most often in Blood Adv. Dr. Owens' most frequent co-authors are Paul A. Hamlin, MD, Ariela Noy, MD and Andrew D. Zelenetz, MD.

CMS Open Payments shows 2 general payments to Dr. Owens from 2 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. Seagen Inc. paid the most, $120.

Dr. Owens graduated from Rutgers Robert Wood Johnson Medical School in 2010.

Dr. Owens is in network with 12 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.